My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Psicothema
On-line version ISSN 1886-144XPrint version ISSN 0214-9915
Abstract
PEREIRA-ABELLO, Cristóbal; CUESTA-IZQUIERDO, Marcelino; LOPEZ-ALVAREZ, Laudino and GARCIA-VIEJO, Alfonso. Identification of neuropsychiatric symptoms in preclinical and prodromal stages in dementias: development of a screening test for mild behavioral impairment. Psicothema [online]. 2024, vol.36, n.1, pp.91-99. Epub Jan 29, 2024. ISSN 1886-144X. https://dx.doi.org/10.7334/psicothema2023.40.
Background:
Neuropsychiatric symptoms (NPS) are a psychopathological dimension of neurodegenerative diseases, consisting of personality changes, behavioral disorders, and alterations in basic functions such as appetite or sleep, among others. The aim of this study was the construction and validation of a screening test to identify these NPS associated with neurodegenerative pathologies in preclinical and prodromal stages, based on the ISTAART criteria for Mild Behavioral Impairment (MBI).
Method:
The sample consisted of 206 subjects over 55 years old (117 cognitively healthy, 89 with Mild Cognitive Impairment). 69% were women, the mean age was 77 years (SD = 10.58).
Results:
The new scale consists of 19 items and exhibited a one-dimensional structure. Confidence was excellent (α = .94 and Ω = .97) and there was evidence of convergent validity with the MBI-C test (r = .88) and the NPI-Q (r = .82). In addition, the scale demonstrated good sensitivity (.88) and specificity (.80).
Conclusions:
The scale allows evaluation of NPS in DCoL. It exhibits good psychometric properties and makes a useful tool in early diagnosis of neurodegenerative pathologies.
Keywords : Mild behavioral impairment; Mild cognitive impairment; dementia; neuropsychiatric symptoms.